<DOC>
	<DOCNO>NCT01503957</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Nasya reduce symptom persistent allergic rhinitis apply allergen challenge .</brief_summary>
	<brief_title>Nasya Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>History persistent allergic rhinitis due house dust mite allergy â‰¥ 2 year Written inform consent Clinically significant disease could interfere evaluation study medication Participation study within last 4 week / study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Allergic rhinitis</keyword>
	<keyword>Allergen</keyword>
	<keyword>Allergy</keyword>
	<keyword>Dustmite</keyword>
</DOC>